Purple Biotech (PPBT) Net Income Growth (3y) (2017 - 2026)
Purple Biotech (PPBT) Net Income Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
30.59% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-46.86% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
19.97% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Purple Biotech |
242.86 Mn |
236.43 Mn |
- |
-22.82% |
| Date | Value |
|---|
| Mar 31, 2026 |
-22.82% |
| Dec 31, 2025 |
58.39% |
| Sep 30, 2025 |
-37.62% |
| Jun 30, 2025 |
-35.59% |
| Mar 31, 2025 |
-43.32% |
| Dec 31, 2024 |
-15.05% |
| Sep 30, 2024 |
98.80% |
| Jun 30, 2024 |
1,064.22% |
| Mar 31, 2024 |
217.53% |
| Dec 31, 2023 |
337.68% |
| Dec 31, 2022 |
19.44% |
| Dec 31, 2021 |
-51.83% |
| Dec 31, 2020 |
-82.32% |
| Dec 31, 2019 |
-21.80% |
| Dec 31, 2018 |
-9.35% |
| Dec 31, 2017 |
189.70% |
